The degree of bone marrow fibrosis in chronic myelogenous leukemia is not a prognostic factor with imatinib mesylate therapy
Kantarjian, Hagop M, Bueso-Ramos, Carlos E, Talpaz, Moshe, O'Brien, Susan, Giles, Francis, Rios, Mary Beth, Shan, Jianqin, Cortes, JorgeVolume:
46
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428190500097581
Date:
January, 2005
File:
PDF, 203 KB
english, 2005